Select Page

Michael Wishart

Forum Replies Created

Viewing 6 posts - 16 through 21 (of 21 total)
  • Author
    Posts
  • in reply to: Re: CVAD insertion checklist #70143
    Avatar photoMichael Wishart
    Participant

    Author:
    Michael Wishart

    Email:
    michael.wishart@internode.on.net

    Organisation:
    St Vincent's Private Hospital Northside

    State:
    QLD

    Michael Wishart
    Infection Control Coordinator
    St Vincent's Private Hospital Northside & St Vincent's Private Hospital Brisbane
    Brisbane, QLD
    michael.wishart@svha.org.au

    in reply to: Re: H7N9 influenza #69920
    Avatar photoMichael Wishart
    Participant

    Author:
    Michael Wishart

    Email:
    michael.wishart@internode.on.net

    Organisation:
    St Vincent's Private Hospital Northside

    State:
    QLD

    Hi Emmajane

    The WHO link the he message was correct, but just didn’t parse correctly.

    Try this:

    http://www.who.int/influenza/human_animal_interface/faq_H7N9/en/index.html

    Cheers
    Michael Wishart
    ACIPC Infexion Connexion Administrator

    On 06/04/2013 19:39, Emmajane Odonoghue wrote:
    > Hi Michael
    > The WHO address came up as page not found.
    > Any chance you may be able to check same?
    > Thanks
    > Emmajane
    >
    > Emmajane O’Donoghue
    >
    > Infection Control Consultant
    > HICMR Pty Ltd
    > (Healthcare Infection Control Management Resources)
    > Level 1, 123 Camberwell Road, Hawthorn East 3123
    > Ph: (03) 98119923 Fax: (03) 98824534
    > National pager number: 1300-657-359
    > http://www.hicmr.com.au
    >
    >
    > —–Original Message—–
    > From: ACIPC Infexion Connexion [mailto:AICALIST@AICALIST.ORG.AU] On Behalf Of Michael Wishart
    > Sent: Saturday, 6 April 2013 10:47
    > To: AICALIST@AICALIST.ORG.AU
    > Subject: H7N9 influenza
    >
    > [Forwarded on behalf of Claire Boardman – Moderator]
    >> Information for clinicians
    >>
    >> As you’d be aware, human cases of H7N9 influenza has been reported in
    >> China. Some information for clinicians (received from Dr Gary Lum at
    >> Office of Health Protection and summarized with permission), current
    >> as of Friday 5 April.
    >>
    >> 1. The number of confirmed patients is 11, including 5 fatalities.
    >>
    >> 2. There continues to be no evidence of human-to-human transmission
    >> and no epidemiological links between patients have been found.
    >>
    >> 3. All the patients detected to date have been seriously unwell.
    >>
    >> 4. Cases have been clustered in the central eastern provinces (3
    >> Shanghai; 1 Anhiu; 4 Jiangning and 3 Zhejiang). These are the
    >> provinces around the cities of Shanghai and Nanjing.
    >>
    >> 5. Analyses indicate that this virus is resistant to adamantanes but
    >> susceptible to oseltamivir.
    >>
    >> 6. This virus is subtyped as LPAI (for birds) H7N9 and appears to be
    >> an assortment of 3 avian viruses; the first 3 strains have been
    >> sequenced and appear to be closely related genetically.
    >>
    >> Testing
    >>
    >> PCR protocols have been developed and web-based publication is
    >> planned. Export of the virus to allow validation is also planned.
    >> Testing of suspected cases in Australia should be performed in
    >> consultation with jurisdictional public health units and reference
    >> laboratories.
    >>
    >> Further information for clinicians is being developed by CDNA.
    >>
    >> Historically
    >>
    >> No previous cases of H7 in humans have been reported in China (or
    >> Asia) prior to these cases
    >>
    >> Infection with H7 viruses is rare in humans, but viruses from both
    >> lineages (North American and Eurasian) have caused infection
    >> previously. Observed symptoms include conjunctivitis and mild
    >> respiratory symptoms. One fatal case (pneumonia) with HPAI H7N7 was
    >> reported in the Netherlands in 2003.
    >>
    >> Most human cases of H7 have been linked to occupational exposure (i.e.
    >> contact with poultry or laboratory exposure)
    >>
    >> The virus appears resistant to amantanes (e.g., amantadine) and
    >> susceptible to neurominidase inhibitors (oseltamivir and zanamivir).
    >>
    >> Further information is also available on the WHO website:
    >> http://www.who.int/influenza/human_animal_interface/faq_H7N9/en/index.
    >> html
    >>
    >> Allen
    >>
    >> —
    >> Allen Cheng
    >> Associate Professor in Infectious Diseases Epidemiology Department of
    >> Epidemiology and Preventive Medicine Monash University
    >>
    >> Infectious Diseases Physician
    >> Alfred Hospital
    >>
    >> Honorary Principal Research Fellow
    >> Menzies School of Health Research
    >>
    > Messages posted to this list are solely the opinion of the authors, and do not represent the opinion of ACIPC.
    >
    > Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
    >
    > Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au
    >
    > To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.
    >
    > You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au
    >
    > Messages posted to this list are solely the opinion of the authors, and do not represent the opinion of ACIPC.
    >
    > Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
    >
    > Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au
    >
    > To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.
    >
    > You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    Messages posted to this list are solely the opinion of the authors, and do not represent the opinion of ACIPC.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    Michael Wishart
    Infection Control Coordinator
    St Vincent's Private Hospital Northside & St Vincent's Private Hospital Brisbane
    Brisbane, QLD
    michael.wishart@svha.org.au

    in reply to: Re: Reprocessing of Savary Gilliard dilators #69737
    Avatar photoMichael Wishart
    Participant

    Author:
    Michael Wishart

    Email:
    michael.wishart@internode.on.net

    Organisation:
    St Vincent's Private Hospital Northside

    State:
    QLD

    Hi Joanna

    STERRAD is a hydrogen peroxide gas plasma sterilisation process. During
    sterilisation the hydrogen peroxide is not a gas state, it is a plasma
    state (the so-called fourth state of matter –
    http://en.wikipedia.org/wiki/Plasma_%28physics%29). Sterilisation with
    hydrogen peroxide plasma has quite different permeation and
    sterilisation properties than gas sterilisation like EtO.

    Cheers
    Michael Wishart
    ICP

    On 22/02/2013 17:38, Joanna Harris wrote:
    > Thanks for your reply Michael. I may have not have written it clearly enough, but my question about the Sterrad relates to whether, in Australia, the Sterrad is considered a gas steriliser. My colleagues and I have always understood that the term gas steriliser refers to processing using Ethylene oxide rather than hydrogen peroxide in a Sterrad. I’m interested to hear others’ views
    > Jo
    > ________________________________________
    > From: ACIPC Infexion Connexion [AICALIST@AICALIST.ORG.AU] On Behalf Of Michael Wishart [Michael.Wishart@hsn.org.au]
    > Sent: Friday, 22 February 2013 1:01 PM
    > To: AICALIST@AICALIST.ORG.AU
    > Subject: Re: Reprocessing of Savary Gilliard dilators
    >
    > Hi Joanna
    >
    >
    > 1. We process our oesophageal dilators through our Soluscope 3 machines using glutaraldehyde, only in our Endoscopy Department.
    >
    > 2. We use a terminal rinse in the Soluscope 3 which includes an alcohol rinse through the lumens.
    >
    > 3. They are stored flat in their cases, and processed immediately before use. Emergency use is extremely rare here, but it would be almost impossible to process them immediately before emergency use.
    >
    > 4. Sterrad does provide sterilisation, but would possibly be unsuitable for these items due to composition and lumen length/diameter. We would need to get Sterrad and dilator manufacturer agreement they could be appropriately processed in Sterrad.
    >
    > Michael Wishart
    > CNC Infection Control
    > Holy Spirit Northside Private Hospital
    > 627 Rode Road, Chermside, Qld 4032
    > t: (07) 3326 3068 | f: (07) 3607 2226
    > e: Michael.Wishart@hsn.org.au
    > w:www.holyspiritnorthside.org.au
    > Please consider the environment before printing this email
    >
    >
    > From: ACIPC Infexion Connexion [mailto:AICALIST@AICALIST.ORG.AU] On Behalf Of Joanna Harris
    > Sent: Friday, 22 February 2013 10:27 AM
    > To: AICALIST@AICALIST.ORG.AU
    > Subject: Reprocessing of Savary Gilliard dilators
    >
    >
    > We are currently reviewing our reprocessing of Savary-Gilliard oesophageal dilators.
    >
    > Please could you tell me;
    >
    > 1. What process / machine / disinfectant agent are you currently using for reprocessing these items?
    >
    > 2. If a Steris machine is being used, do you use alcohol to flush the lumen prior to storage?
    >
    > 3. How do you store the items, and for how long after processing and before their re-use?
    >
    > 4. Do you consider the Sterrad system (using hydrogen peroxide) to be a gas steriliser?
    >
    > Thanks
    >
    >
    > Joanna Harris
    >
    > Manager, | Infection Management and Control Service (IMACS)
    > Level 1 Lawson House, Wollongong Hospital, Wollongong 2500, NSW
    > Tel 02 4222 5898 | Fax 02 4222 5367 | joanna.harris@sesiahs.health.nsw.gov.au
    > http://www.islhd.health.nsw.gov.au
    >
    > [cid:image001.jpg@01CE10EF.8F8CF190]
    >
    >
    > ———————————————————————————————
    >
    >
    >
    > Illawarra Shoalhaven Local Health District, South East Sydney Local Health District and Sydney Children’s Hospital Network (Randwick Campus) Confidentiality Notice
    >
    >
    >
    > This email, and the files transmitted with it, are confidential and intended solely for the use of the individual or entity to whom they are addressed. If you are not the intended recipient, you are not permitted to distribute or use this email or any of its attachments in any way. We also request that you advise the sender of the incorrect addressing.
    >
    >
    >
    > This email message has been virus-scanned. Although no computer viruses were detected, Illawarra Shoalhaven Local Health District, South East Sydney Local Health District and Sydney Children’s Hospital Network (Randwick Campus) accept no liability for any consequential damage resulting from email containing any computer viruses.
    >
    > Messages posted to this list are solely the opinion of the authors, and do not represent the opinion of ACIPC.
    >
    > Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
    >
    > Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au
    >
    > To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.
    >
    > You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au
    >
    > Message protected by MailGuard: e-mail anti-virus, anti-spam and content filtering.
    > http://www.mailguard.com.au/mg
    >
    > Report this message as spam
    >
    >
    > WARNING : This email contains information, which is CONFIDENTIAL, and that maybe subject to LEGAL PRIVILEGE. This e-mail and any attachments to it (the “Communication”) is confidential and is for the use only of the intended recipient, and may not duplicated or used by any other party without the express consent of the sender. The Communication may contain copyright material of St Vincent’s Health & Aged Care(“SVHAC”), or any of its related entities or of third parties. If you are not the intended recipient of the Communication, please notify the sender immediately by return e-mail, delete the Communication, and do not read, copy, print, retransmit, store or act in reliance on the Communication. Any views expressed in the Communication are those of the individual sender only, unless expressly stated to be those of SVHAC. SVHAC does not guarantee the integrity of the Communication, or that it is free from errors, viruses or interference. Thank-you.
    >
    >
    >
    > Message protected by MailGuard: e-mail anti-virus, anti-spam and content filtering.
    > http://www.mailguard.com.au/mg
    >
    >
    >
    > Messages posted to this list are solely the opinion of the authors, and do not represent the opinion of ACIPC.
    >
    > Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
    >
    > Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au
    >
    > To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.
    >
    > You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au
    >
    > ———————————————————————————————
    >
    > Illawarra Shoalhaven Local Health District, South East Sydney Local Health District and Sydney Children’s Hospital Network (Randwick Campus) Confidentiality Notice
    >
    > This email, and the files transmitted with it, are confidential and intended solely for the use of the individual or entity to whom they are addressed. If you are not the intended recipient, you are not permitted to distribute or use this email or any of its attachments in any way. We also request that you advise the sender of the incorrect addressing.
    >
    > This email message has been virus-scanned. Although no computer viruses were detected, Illawarra Shoalhaven Local Health District, South East Sydney Local Health District and Sydney Children’s Hospital Network (Randwick Campus) accept no liability for any consequential damage resulting from email containing any computer viruses.
    >
    > Messages posted to this list are solely the opinion of the authors, and do not represent the opinion of ACIPC.
    >
    > Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
    >
    > Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au
    >
    > To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.
    >
    > You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au
    >

    Messages posted to this list are solely the opinion of the authors, and do not represent the opinion of ACIPC.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    Michael Wishart
    Infection Control Coordinator
    St Vincent's Private Hospital Northside & St Vincent's Private Hospital Brisbane
    Brisbane, QLD
    michael.wishart@svha.org.au

    Avatar photoMichael Wishart
    Participant

    Author:
    Michael Wishart

    Email:
    michael.wishart@internode.on.net

    Organisation:
    St Vincent's Private Hospital Northside

    State:
    QLD

    Michael Wishart
    Infection Control Coordinator
    St Vincent's Private Hospital Northside & St Vincent's Private Hospital Brisbane
    Brisbane, QLD
    michael.wishart@svha.org.au

    Avatar photoMichael Wishart
    Participant

    Author:
    Michael Wishart

    Email:
    michael.wishart@internode.on.net

    Organisation:
    St Vincent's Private Hospital Northside

    State:
    QLD

    Michael Wishart
    Infection Control Coordinator
    St Vincent's Private Hospital Northside & St Vincent's Private Hospital Brisbane
    Brisbane, QLD
    michael.wishart@svha.org.au

    in reply to: Needleless IV admin sets #68307
    Avatar photoMichael Wishart
    Participant

    Author:
    Michael Wishart

    Email:
    michael.wishart@internode.on.net

    Organisation:
    St Vincent's Private Hospital Northside

    State:
    QLD

    Michael Wishart
    Infection Control Coordinator
    St Vincent's Private Hospital Northside & St Vincent's Private Hospital Brisbane
    Brisbane, QLD
    michael.wishart@svha.org.au

Viewing 6 posts - 16 through 21 (of 21 total)